{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:35:34Z","timestamp":1768883734322,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jss.2017.03.039","type":"journal-article","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T17:34:08Z","timestamp":1490981648000},"page":"55-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Use of axillary lymph node dissection (ALND) in patients with micrometastatic breast cancer"],"prefix":"10.1016","volume":"215","author":[{"given":"Madison","family":"Collins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"O'Donoghue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Laronga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Catherine","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2017.03.039_bib1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.amjsurg.2006.05.014","article-title":"Presentation: accuracy of intraoperative imprint cytology of sentinel lymph nodes in breast cancer","volume":"192","author":"Pugliese","year":"2006","journal-title":"The Am J Surg"},{"key":"10.1016\/j.jss.2017.03.039_bib2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1073\/pnas.72.3.1059","article-title":"N-formylmethionyl peptides as chemoattractants for leucocytes","volume":"72","author":"Schiffmann","year":"1975","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jss.2017.03.039_bib3","first-page":"83","article-title":"Axillary recurrences following positive sentinel lymph node biopsy with individual tumor cells or micrometastases and no axillary dissection","volume":"31","author":"Tjan-Heijnen","year":"2011","journal-title":"Breast Dis"},{"key":"10.1016\/j.jss.2017.03.039_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1245\/ASO.2003.05.020","article-title":"Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer","volume":"10","author":"Hwang","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2017.03.039_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/000313480407000202","article-title":"Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer","volume":"70","author":"Saidi","year":"2004","journal-title":"Am Surg"},{"key":"10.1016\/j.jss.2017.03.039_bib6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/bjs.5943","article-title":"A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive","volume":"95","author":"Pal","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.jss.2017.03.039_bib7","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1245\/ASO.2003.03.015","article-title":"A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy","volume":"10","author":"Van Zee","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2017.03.039_bib8","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1200\/JCO.2008.19.7418","article-title":"Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study","volume":"27","author":"Coutant","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2017.03.039_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10549-004-5781-z","article-title":"An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement","volume":"91","author":"Barranger","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jss.2017.03.039_bib10","first-page":"1","article-title":"Treatment plan for breast cancer with sentinel node metastasis","volume":"8","author":"Abreu","year":"2014","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.jss.2017.03.039_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10434-999-0109-1","article-title":"The impact of prophylactic axillary node dissection on breast cancer survival\u2013a Bayesian meta-analysis","volume":"6","author":"Orr","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2017.03.039_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.currproblcancer.2012.06.003","article-title":"Axillary dissection","volume":"36","author":"Chen","year":"2012","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.jss.2017.03.039_bib13","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJM199004123221505","article-title":"Indicators of prognosis in node-negative breast cancer","volume":"322","author":"Sigurdsson","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2017.03.039_bib14","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ejso.2013.03.012","article-title":"Completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution","volume":"6","author":"Grabau","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jss.2017.03.039_bib15","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10549-011-1486-2","article-title":"Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?","volume":"3","author":"Galimberti","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jss.2017.03.039_bib16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jss.2017.03.039_bib17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2325\/jbcs.14.350","article-title":"Intraoperative imprint cytology for the diagnosis of sentinel node metastases in breast cancer","volume":"14","author":"Motomura","year":"2007","journal-title":"Breast Cancer"},{"key":"10.1016\/j.jss.2017.03.039_bib18","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1245\/s10434-016-5177-4","article-title":"Sentinel lymph node biopsy versus axillary dissection in node-negative early-stage breast cancer: 15-year follow-up update of a randomized clinical trial","volume":"23","author":"Canavese","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2017.03.039_bib19","unstructured":"Breast Cancer Treatment Guidelines version 2.2016. National Comprehensive Cancer Network (NCCN), Fort Washington, PA. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf. Accessed August 24, 2016."},{"key":"10.1016\/j.jss.2017.03.039_bib20","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1245\/s10434-016-5151-1","article-title":"Late axillary recurrence after negative sentinel lymph node biopsy is uncommon","volume":"23","author":"Matsen","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2017.03.039_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.clbc.2016.05.018","article-title":"Original study: should we perform the intraoperative sentinel lymph node biopsy in breast cancer?","author":"Ceberio","year":"2016","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.jss.2017.03.039_bib22","doi-asserted-by":"crossref","first-page":"803s","DOI":"10.1200\/jco.2009.27.18_suppl.cra506","article-title":"Impact of omission of completion axillary lymph node dissection (cALND) or axillary radiotherapy (ax RT) in breast cancer patients with micrometastases (pN1mi) or isolated tumor cells (pNO[i+]) in the sentinel lymph node (SN): results from the MIRROR","volume":"27","author":"Tjan-Heijnen","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2017.03.039_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1503\/cjs.007810","article-title":"Factors that determine whether a patient receives completion axillary lymph node dissection after a positive sentinel lymph node biopsy for breast cancer in British Columbia","volume":"4","author":"Aslani","year":"2011","journal-title":"Can J Surg"},{"key":"10.1016\/j.jss.2017.03.039_bib24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/01.sla.0000245472.47748.ec","article-title":"Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients","volume":"245","author":"Langer","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2017.03.039_bib25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients\u00a0with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"4","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jss.2017.03.039_bib26","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","article-title":"Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011","volume":"25","author":"Lucci","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2017.03.039_bib27","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1245\/s10434-010-1155-4","article-title":"Morbidity of sentinel node biopsy in breast cancer: the relationship between the number of excised lymph nodes and lymphedema","volume":"17","author":"Goldberg","year":"2010","journal-title":"Ann Surg Oncol An Oncol J Surgeons"},{"key":"10.1016\/j.jss.2017.03.039_bib28","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1200\/JCO.2008.16.3725","article-title":"Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements","volume":"26","author":"McLaughlin","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480417301658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480417301658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T23:29:08Z","timestamp":1692746948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480417301658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":28,"alternative-id":["S0022480417301658"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2017.03.039","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of axillary lymph node dissection (ALND) in patients with micrometastatic breast cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2017.03.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}